Related by context. Frequent words. (Click for all words.) 84 evaluable 71 tumor shrinkage 68 mg BID 68 free survival PFS 66 FOLFOX 66 tumor regression 65 dose escalation 64 hematologic 64 dose limiting toxicities 64 dasatinib 63 liver metastases 63 IMGN# 63 mg/m2 63 tumor recurrence 63 primary endpoint 63 imatinib 62 bortezomib 62 secondary endpoint 62 gefitinib 62 Phase 1b 61 dose escalation study 61 mg dose 61 vandetanib 61 randomized Phase 61 randomized 61 docetaxel 61 NSCLC 61 plus ribavirin 61 monotherapy 61 n = 61 infliximab 61 HCV RNA 61 gemcitabine 60 ACTEMRA 60 adalimumab 60 sunitinib 60 Phase 2b study 60 peginterferon 60 rituximab 60 primary efficacy endpoint 59 Median survival 59 mitoxantrone 59 Phase Ib 59 febrile neutropenia 59 etanercept 59 follicular lymphoma 59 brain metastases 58 ZYBRESTAT 58 pegylated interferon 58 postoperatively 58 antitumor activity 58 zoledronic acid 58 Phase 2a clinical 58 pharmacodynamic 58 statistically significant improvement 58 phase IIb 58 HRPC 57 secondary endpoints 57 lenalidomide 57 Phase IIa trial 57 placebo controlled 57 AP# [003] 57 FOLOTYN 57 carboplatin 57 CYT# 57 sorafenib 57 Phase IIa clinical 57 mg kg 57 cetuximab 57 Cotara 57 trastuzumab 57 disease progression 56 Phase 2b trial 56 bone metastases 56 HbA1c levels 56 primary endpoints 56 bevacizumab 56 unblinded 56 efficacy endpoints 56 relapsing remitting multiple sclerosis 56 log# 56 copies mL 56 fludarabine 56 metastatic disease 56 adjuvant therapy 56 Vectibix 56 blinatumomab 56 demonstrated statistically significant 56 erlotinib 56 ofatumumab 56 randomization 56 anastrozole 55 tolerability 55 dexamethasone 55 relapsing remitting MS 55 satraplatin 55 Phase 2b clinical 55 panitumumab 55 adjuvant chemotherapy 55 LVEF 55 mg m